Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects

Clinical Oral Investigations

Volumn 10, Issue 3, 2006, Pages 227-234

  Kuru, Bahar ^a,b   Yilmaz, Selçuk ^b   Argin, Kiliçaslan ^b   Noyan, Ülkü ^a,b  

^a MARMARA UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Bioactive glass; Bone grafts; Enamel matrix protein derivative; Intrabony defects; Periodontal regeneration

Indexed keywords

BIOGLASS; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN;

ADULT; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; CERAMICS; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECT; HUMAN; OSTEOLYSIS; PERIODONTITIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; ALVEOLAR BONE LOSS; BONE REGENERATION; BONE SUBSTITUTES; CERAMICS; CHRONIC DISEASE; DENTAL ENAMEL PROTEINS; DRUG COMBINATIONS; HUMANS; PERIODONTITIS; SINGLE-BLIND METHOD;

EID: 33747267536     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-006-0052-5     Document Type: Article

References (50)

1. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenney EB, Madzarevic M (2001) The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans. J Clin Periodontol 28:1016-1022
2. Cattaneo V, Rota C, Silvestri M, Piacentini C, Forlino A, Gallanti A, Rasperini G, Cetta G (2003) Effect of enamel matrix derivative on human periodontal fibroblasts: Proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res 38:568-574
3. Christgau M, Schmalz G, Reich E, Wenzel A (1995) Clinical and radiographical split-mouth-study on resorbable versus non-resorbable GTR-membranes. J Clin Periodontol 22:306-315
4. Cochran DL, Jones A, Heijl L, Mellonig JT, Schoolfield J, King GN (2003) Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. J Clin Periodontol 74:1269-1281
5. Cochran DL, King GN, Schoolfield J, Velasquez-Plata D, Mellonig JT, Jones A (2003) The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses. J Clin Periodontol 74:1043-1055
6. Donos N, Sculean A, Glavind L, Reich E, Karring T (2003) Wound healing of degree III furcation involvements following guided tissue regeneration and/or Emdogain. A histologic study. J Clin Periodontol 30:1061-1068
7. Fetner A, Hartigan M, Low S (1994) Periodontal repair using Perioglass in non-human primates: Clinical and histological observations. Compendium (Newt. Pa.) 7:932-938
8. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry. J Clin Periodontol 72:25-34
9. Garrett S (1996) Periodontal regeneration around natural teeth. In: Newman MG (ed) Annals of periodontology. The American Academy of Periodontology, Chicago, pp 621-666
10. Gunsolley J, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Clin Periodontol 69:521-527
11. Haase H, Bartold PM (2001) Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. J Clin Periodontol 72:341-348
12. Hammarstrom L (1997) Enamel matrix, cementum development and regeneration. J Clin Periodontol 24:658-668
13. Heden G (2000) A case report study of 72 consecutive Emdogain-treated intrabony defects: Clinical and radiographic findings after 1 year. Int J Periodontics Restor Dent 20:127-139
14. Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693-696
15. Heijl L, Heden G, Svardström G, Östgren A (1997) Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705-714
16. Karatzas S, Zavras A, Greenspan D, Amar S (1999) Histologic observations of periodontal wound healing after treatment with PerioGlas in nonhuman primates. Int J Periodontics Restor Dent 19:489-499
17. Kiliç AR, Efeog̈lu E, Yilmaz S (1997) Guided tissue regeneration in conjunction with hydroxyapatite-collagen grafts for intrabony defects. A clinical and radiological evaluation. J Clin Periodontol 24:372-383
18. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Clin Periodontol 71:1110-1116
19. Lindhe J, Westfelt E, Nyman S, Socransky SS, Heijl L, Bratthall G (1982) Healing following surgical/non-surgical treatment of periodontal disease. A clinical study. J Clin Periodontol 9:115-128
20. Mellonig JT (1999) Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restor Dent 19:9-19
21. Mühlemann HR, Son S (1971) Gingival sulcus bleeding: A leading symptom in initial gingivitis. Helv Odontol Acta 15:107-112
22. Nevins ML, Camelo M, Nevins M, King CJ, Oringer RJ, Schenk RK, Fiorellini JP (2000) Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restor Dent 20:458-467
23. Pietruska MD (2001) A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 109:178-181
24. Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833-840
25. Quintero G, Mellonig JT, Gambill VM, Pelleu GB Jr (1982) A six-month clinical evaluation of decalcified freeze-dried bone allografts in periodontal osseous defects. J Clin Periodontol 53:726-730
26. Rosen P, Reynolds MA (2002) A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Clin Periodontol 73:942-949
27. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT (2002) A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects. J Clin Periodontol 73:423-432
28. Sculean A, Donos N, Blaes A, Lauermann M, Reich E, Brecx M (1999) Comparison of enamel matrix proteins an bioabsorbable membranes in the treatment of intrabony defects. A split-mouth study. J Clin Periodontol 70:255-262
29. Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310-322
30. Sculean A, Reich E, Chiantella CG, Brecx M (1999) Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases. Int J Periodontics Restor Dent 19:157-163
31. Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restor Dent 20:375-381
32. Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 27:466-472
33. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397-403
34. Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M (2002) Clinical evaluation of an enamel matrix derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Clin Periodontol 73:401-408
35. Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS (2002) Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Investig 6:183-187
36. Sculean A, Windisch P, Keglevich T, Chiantella CG, Gera I, Donos N (2003) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine derived xenograft. Int J Periodontics Restor Dent 23:47-55
37. Sculean A, Pietruska M, Schwartz F, Willershausen B, Arweiler NB, Auschill TM (2005) Healing of human intrabony defects following regenerative periodontal therapy with an enemal matrix protein derivative alone and combinated with a bioactive glass. J Clin Periodontol 32:111-117
38. Sculean A, Windisch P, Keglevich Gera I (2005) Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restor Dent 25:139-147
39. Silness J, Löe H (1964) Periodontal disease in pregnancy (II). Correlation between oral hygiene and periodontal conditioning. Acta Odontol Scand 22:121-135
40. Silverstein LH (2005) Suture selection for optimal flap closure and tissue healing. Perio-implant showcase. Pract Periodontics Aesthet Dent 16:2-3
41. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V (2000) Comparison of treatments of intrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol 27:603-610
42. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adrian P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedman C, Topoll H, Vangsted T, Walkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 9:317-325
43. Velasquez-Plata D, Scheyer TE, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 73:433-440
44. Wikesjö UME, Selvig KA (1999) Periodontal wound healing and regeneration. Periodontol 2000 19:21-39
45. Wilson J, Low (1992) Bioactive ceramics for periodontal treatment: comparative study in the patus monkey. J Appl Biomater 3:123-129
46. Wilson J, Clark AE, Hall M, Hench LL (1993) Tissue response to Bioglass endosseous ridge maintenance implants. J Oral Implantol 19:295-302
47. Yilmaz S, Kuru B, E (2003) Enamel matrix proteins in the treatment of periodontal sites with horizontal type of bone loss. J Clin Periodontol 30:197-206
48. Yukna RA, Mellonig J (2000) Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 71:752-759
49. Zetterstrom O, Andersson C, Eriksson C (1997) Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 24:697-704
50. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 74:1725-1735